Christian B. Voigtlander - 20 May 2025 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Signature
By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander
Issuer symbol
ICUI
Transactions as of
20 May 2025
Net transactions value
-$246,059
Form type
4
Filing time
21 May 2025, 16:23:28 UTC
Previous filing
19 May 2025
Next filing
23 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Voigtlander Christian B. Chief Operating Officer 951 CALLE AMANECER, SAN CLEMENTE By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander 21 May 2025 0001727477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $537,891 +5,555 +233% $96.83 7,944 20 May 2025 Direct
transaction ICUI Common Stock Sale $667,879 -4,871 -61% $137.11 3,073 20 May 2025 Direct F1
transaction ICUI Common Stock Options Exercise $537,891 +5,555 +181% $96.83 8,628 21 May 2025 Direct
transaction ICUI Common Stock Sale $653,961 -4,917 -57% $133.00 3,711 21 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,555 -17% $0.000000 27,780 20 May 2025 Common Stock 5,555 $96.83 Direct
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,555 -20% $0.000000 22,225 21 May 2025 Common Stock 5,555 $96.83 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.92 to $137.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 All shares sold were sold at the exact price disclosed.